Pharmacokinetics of methadone during maintenance treatment: Adaptive changes during the induction phase
Authors:
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 22 (4) , 343-349
Abstract
Deuterated methadone (M-d30) and GC-MS were used to study the pharmacokinetics of methadone (M) during the induction stage of methadone maintenance treatment (MMT). A pulse dose of M-d3 was given on Days 1 and 25 of two dosage regimens, one with a continuous 30 mg dose (n=6), and the other with 30 mg for 10 days, followed by 60 mg as the maintenance dose (n=6). Plasma and urinary levels of M and M-d3 were measured throughout and plasma half-lives, oral bioavailabilities and volumes of distribution were calculated from the data of Days 1–2 and 24–26. The oral bioavailability of a methadone solution was found to be between 81 and 95%; elimination half-life in the β-phase varied between 19 and 58 h; the volume of distribution was 4.1±0.65 l/kg; and total body clearance of M was 54–195 ml/min and its renal clearance 3.4–34 ml/min. A consistent finding was a lower urinary pH and increased renal clearance during the first days of MMT as compared with after one month. In 4/12 of the patients dispositional tolerance was developed to methadone during the first month of treatment. The shorter elimination half-lives in those patients probably caused unacceptably high fluctuation in the body content of M during the 24 h dosage interval, and may have interfered therefore, with its therapeutic effectivenessKeywords
This publication has 15 references indexed in Scilit:
- Effect of urinary pH on the disposition of methadone in manEuropean Journal of Clinical Pharmacology, 1982
- Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope methodEuropean Journal of Clinical Pharmacology, 1981
- Clinical eftects and pharmacokinetics of racemic methadone and its optical isomersClinical Pharmacology & Therapeutics, 1977
- Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatmentClinical Pharmacology & Therapeutics, 1975
- Mass fragmentographic determination of unlabeled and deuterium labeled methadone in human plasma. Possibilities for measurement of steady state pharmacokineticsJournal of Mass Spectrometry, 1975
- Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochlorideClinical Pharmacology & Therapeutics, 1975
- Disposition of methadone in methadone maintenanceClinical Pharmacology & Therapeutics, 1975
- Effect of oral administration of methadone on hepatic microsomal mixed function oxidase activity in miceLife Sciences, 1974
- Disposition of methadone in man after a single oral doseClinical Pharmacology & Therapeutics, 1972
- The levels of methadone in the plasma in methadone maintenanceClinical Pharmacology & Therapeutics, 1972